BRONCOMEDICAL

This brand name is authorized in Spain.

Active ingredients

The drug BRONCOMEDICAL contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Guaiacolsulfonate UNII `21A795TNZD` - POTASSIUM GUAIACOLSULFONATE ANHYDROUS
	Read more about Guaiacolsulfonate
`2`	Demorphan UNII `9D2RTI9KYH` - DEXTROMETHORPHAN HYDROBROMIDE
	Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors.
	Read more about Demorphan

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05FA02	Opium derivatives and expectorants	R Respiratory system → R05 Cough and cold preparations → R05F Cough suppressants and expectorants, combinations → R05FA Opium derivatives and expectorants
Discover more medicines within R05FA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	50456

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.